@xconomy.com 18 days ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com 2 months ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com 2 months ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com 3 months ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@SpirosMargaris 3 months ago
COVID-19 might be bitter #medicine for what ails #AI #investing https://buff.ly/2XA5Fk9 #fintech #VC #startup #ArtificiallIntelligence #MachineLearning #DeepLearning #covid19 #coronavirus @SiliconANGLE @Paula_Piccard @andi_staub @SabineVdL @psb_dc @Fisher85M @ipfconline1 https://t.co/7dcYVuXtNq
@xconomy.com 4 months ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com 4 months ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com 4 months ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 7 months ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com 7 months ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com 8 months ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com 11 months ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com 1 year ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com 1 year ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com 1 year ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com 1 year ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com 1 year ago
From Farm to (Financial) Table: Holt Ventures Partner Meg Paulus
@xconomy.com 1 year ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com 1 year ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@CuresToken 1 year ago
Do you agree with King's point? You are a believer in better healthcare? The time to act is now. Become an early contributor and get the most of it with CURES: http://bit.ly/2WUoq0K #blockchain #healthcare #innovation #investing #machinelearning #medicaldata #technology https://t.co/sVP54hA830
@xconomy.com 1 year ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com 1 year ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com 1 year ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com 1 year ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com 1 year ago
Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot
@xconomy.com 1 year ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com 1 year ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com 2 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com 2 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com 2 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com 2 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com 2 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@euprime_org 3 years ago
Fluorides #chemistry #euprime #StockMarket #investing #mumbai #nse #trading #Medical #agriculture #equity #share… https://twitter.com/i/web/status/834290768378462208